Perjeta approved for advanced breast cancer
The FDA has approved Perjeta (pertuzumab) for the treatment of HER2-positive late-stage breast cancer.
Diagnosis & Disease Information
Votrient approved to treat advanced soft tissue sarcoma
Drug inhibits process that fuels tumor growth.
Vemurafenib for melanoma and other cancers
One of the major cancer medicine success stories of 2011 was the FDA approval of vemurafenib (Zelboraf ®; Genentech/Daiichi Sankyo) for metastatic melanoma.
FDA Update: Latest cancer drug approvals and warnings
Enhanced coverage of this issue’s FDA Update plus a video on the Hedgehog pathway.
FDA Update: December 2011
In November and December 2011, the FDA approved a number of new cancer drugs. Highlights include cetuximab for head and neck cancer, Hemacord, and asparaginase Erwinia chrysanthemi for ALL.
- Loading...
Loading...
Loading... 
Loading...